Congenital Heart Walks Announced in 26 Communities Nationwide in 2018 Philadelphia, April 17, 2018 (GLOBE NEWSWIRE) -- To support, honor and remember the millions of children, adults and families impacted by congenital heart disease (CHD), The Children’s Heart...

Asklepion Pharmaceuticals Presents Phase 1b/2a Clinical Trial Data for IV-Citrulline at the Pediatric Cardiac Intensive Care Society 13th Annual International Meeting BALTIMORE, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Asklepion Pharmaceuticals, LLC (“Asklepion” or “the Company”), a biotechnology company focused on the development of IV-citrulline for rare pediatric...